polymerase chain reaction

Merger Launches OSPRI, a Next‑Gen North Texas PCR Testing Company Backed by Up to $30M

by | Aug 20, 2025
Formed by a merger among Community Direct DX (CDx), Scienetix, and the R&D division of Advanta Genetics, OSPRI specializes in polymerase chain reaction (PCR)-based infectious disease detection. It develops and delivers advanced tools that improve access to high-quality care across key healthcare segments, the company said.
MORE